Gaborean, V.; Feier, C.V.I.; Vonica, R.C.; Faur, A.M.; Rus, V.I.; Muntean, C.
Salvage Pulmonary Resection After Immune Checkpoint or Tyrosine Kinase Inhibitor Therapy for Initially Unresectable Non-Small-Cell Lung Cancer: A Systematic Review. Biomedicines 2025, 13, 1541.
https://doi.org/10.3390/biomedicines13071541
AMA Style
Gaborean V, Feier CVI, Vonica RC, Faur AM, Rus VI, Muntean C.
Salvage Pulmonary Resection After Immune Checkpoint or Tyrosine Kinase Inhibitor Therapy for Initially Unresectable Non-Small-Cell Lung Cancer: A Systematic Review. Biomedicines. 2025; 13(7):1541.
https://doi.org/10.3390/biomedicines13071541
Chicago/Turabian Style
Gaborean, Vasile, Catalin Vladut Ionut Feier, Razvan Constantin Vonica, Alaviana Monique Faur, Vladut Iosif Rus, and Calin Muntean.
2025. "Salvage Pulmonary Resection After Immune Checkpoint or Tyrosine Kinase Inhibitor Therapy for Initially Unresectable Non-Small-Cell Lung Cancer: A Systematic Review" Biomedicines 13, no. 7: 1541.
https://doi.org/10.3390/biomedicines13071541
APA Style
Gaborean, V., Feier, C. V. I., Vonica, R. C., Faur, A. M., Rus, V. I., & Muntean, C.
(2025). Salvage Pulmonary Resection After Immune Checkpoint or Tyrosine Kinase Inhibitor Therapy for Initially Unresectable Non-Small-Cell Lung Cancer: A Systematic Review. Biomedicines, 13(7), 1541.
https://doi.org/10.3390/biomedicines13071541
